Avai Bio, Inc.
AVAI· OTC
AVAIAvai Bio, Inc.
Filed Nov 12, 2024 · 10-Q · 43 days after period end · 0001740797-24-000054
| Metric | Q2 2025 | Q2 2024 | Q2 2020 | Q2 2019 |
|---|---|---|---|---|
| Net Income | -$623.05K | -$399.62K | $50.46K | -$30.99K |
| EPS Diluted | — | — | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Avai Bio, Inc. · CIK 1740797 · Engraved from SEC EDGAR
ended Sep 30, 2024 · filed Nov 12, 2024 · 43 d after period end
